Literature DB >> 12825456

Selective thyromimetics: tissue-selective thyroid hormone analogs.

T S Scanlan1, H A Yoshihara, N H Nguyen, G Chiellini.   

Abstract

Thyroid hormone coordinates a diverse array of physiological events in development and homeostasis. Many of the actions of thyroid hormone are tissue-specific and are primarily mediated by a panel of thyroid hormone receptor isoforms that are expressed in different ratios in different tissues. Because these tissue-specific hormone signaling pathways are linked to a number of metabolic diseases, the development of synthetic thyroid hormone analogs that have tissue-selective hormone actions (i.e., selective thyromimetics) is highly desirable. There is a powerful collection of tools available today for this pursuit including efficient receptor binding and activation assays, receptor structures and a variety of thyroid hormone receptor knockout mice. The medicinal chemistry efforts in this area demonstrate that selective thyromimetics can be produced from a variety of approaches. These compounds are proving useful as probes to better define thyroid hormone actions and may one day find use in the clinic for the treatment of metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12825456

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  5 in total

1.  Sobetirome prodrug esters with enhanced blood-brain barrier permeability.

Authors:  Andrew T Placzek; Skylar J Ferrara; Meredith D Hartley; Hannah S Sanford-Crane; J Matthew Meinig; Thomas S Scanlan
Journal:  Bioorg Med Chem       Date:  2016-09-16       Impact factor: 3.641

2.  Characterization of thyroid hormone receptor alpha (TRalpha)-specific analogs with varying inner- and outer-ring substituents.

Authors:  Cory A Ocasio; Thomas S Scanlan
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

3.  Thyroid hormone-dependent seasonality in American tree sparrows (Spizella arborea): effects of GC-1, a thyroid receptor beta-selective agonist, and of iopanoic acid, a deiodinase inhibitor.

Authors:  M K Mishra; F E Wilson; T S Scanlan; G Chiellini
Journal:  J Comp Physiol B       Date:  2004-07-02       Impact factor: 2.200

Review 4.  Sobetirome: a case history of bench-to-clinic drug discovery and development.

Authors:  Thomas S Scanlan
Journal:  Heart Fail Rev       Date:  2008-11-11       Impact factor: 4.214

Review 5.  Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.

Authors:  Federica Saponaro; Simona Sestito; Massimiliano Runfola; Simona Rapposelli; Grazia Chiellini
Journal:  Front Med (Lausanne)       Date:  2020-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.